Johnson Johnson shareholders urged to reject CEO’s $30 million payday after year of lawsuits

(Natural News) Johnson & Johnson is coming under scrutiny from investors over CEO Alex Gorsky’s pay package, with critics complaining that the healthcare company is shielding executives from the legal costs of their poor business decisions. In calculating stock awards to top executives, the company excluded costs related to some of the major lawsuits Johnson…  » READ MORE